Persistent hematuria after induction of remission in wegener granulomatosis: A therapeutic dilemma

Medicine

Volumn 88, Issue 6, 2009, Pages 315-321

  Magrey, Marina N ^a   Villa Forte, Alexandra ^b   Koening, Curry L ^c   Myles, Jonathan L ^b   Hoffman, Gary S ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYSTITIS; CYSTOSCOPY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HEADACHE; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALAISE; MALE; NOSE CONGESTION; PRIORITY JOURNAL; PROTEINURIA; RASH; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINALYSIS; URINE; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULONEPHRITIS; HEMATURIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; WEGENER GRANULOMATOSIS;

EID: 72949101301     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181c101cc     Document Type: Article

References (18)

1. Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus. 2005;14:25-30.
2. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314-322.
3. Falk RJ, Jennette JC. Treatment response and relapse in antineutrophil cytoplasmic autoantibody associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:33-39.
4. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore). 1973; 52:535-561.
5. Hill GS, Jenis EH, Goodloe S Jr. The nonspecificity of the ultrastructural alterations in hereditary nephritis with additional observations on benign familial hematuria. Lab Invest. 1974;31:516-532.
6. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
7. Hoffman GS. Wegener's granulomatosis: the path traveled since 1931. Medicine (Baltimore). 1994;73:325-329.
8. Jayne D, Rasmussen N, Andrassy K, Bacon P, Cohen Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44. (Pubitemid 36765101)
9. McCluskey RT, Baldwin DS. Natural history of acute glomerulonephritis. Am J Med. 1963;35:213-230.
10. Mittal BV, Pendse S, Rennke HG, Singh AK. Hematuria in a patient with class IV lupus nephritis. Kidney Int. 2006;70:1182-1186.
11. Rapoport A, Davidson DA, Deveber GA, Ranking GN, McLean CR. Idiopathic focal proliferative nephritis associated with persistent hematuria and normal renal function. Ann Intern Med. 1970;73:921-928.
12. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, Heller M, Gross WL. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021-1032.
13. Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis. 2006;47:770-779.
14. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum. 2001;44:912-920.
15. Sue YM, Huang JJ, Hsieh RY, Chen FF Clinical features of thin basement membrane disease and associated glomerulopathies. Nephrology (Carlton). 2004;9:14-18.
16. Comment in Nephrology (Carlton). 2004;9:52.
17. Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore). 2007;86:269-277.
18. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus tandard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352:351-361.